title: Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.
abstract: The number of memory CD8 T cells generated by infection or vaccination correlates strongly with the degree of protection observed in infection and tumor models. Therefore, rapid induction of protective numbers of effector and memory CD8 T cells may be crucial in the case of malignancy, pandemic infection, or bioterrorism. Many studies have shown that amplifying T-cell numbers by prime-boost vaccination is most effective with a substantial time interval between immunizations. In contrast, immunization with peptide-coated mature dendritic cells (DCs) results in a CD8 T-cell response exhibiting accelerated acquisition of memory characteristics, including the ability to respond to booster immunization within days of initial priming. However, personalized DC immunization is too costly, labor intensive, and time-consuming for large-scale vaccination. Here, we demonstrate that in vivo cross-priming with cell-associated antigens or antigen-coated, biodegradable microspheres in the absence of adjuvant quickly generates CD8 T cells that display the phenotype and function of long-term memory populations. Importantly, cross-primed CD8 T cells can respond to booster immunization within days of the initial immunization to generate rapidly large numbers of effector and memory T cells that can protect against bacterial, viral, and parasitic infections, including lethal influenza and malaria-causing Plasmodium infection. Thus, accelerated CD8 T-cell memory after in vivo cross-priming in the absence of adjuvant is generalizable and can be exploited to generate protective immunity rapidly.
authors.affiliation: Departments of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
authors.forename: Nhat-Long L
authors.initials: NL
authors.lastname: Pham
authors.forename: Lecia L
authors.initials: LL
authors.lastname: Pewe
authors.forename: Courtney J
authors.initials: CJ
authors.lastname: Fleenor
authors.forename: Ryan A
authors.initials: RA
authors.lastname: Langlois
authors.forename: Kevin L
authors.initials: KL
authors.lastname: Legge
authors.forename: Vladimir P
authors.initials: VP
authors.lastname: Badovinac
authors.forename: John T
authors.initials: JT
authors.lastname: Harty
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D045142:Cross-Priming / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology; D007109:Immunity / Q000276:immunology*; D007114:Immunization / Q000379:methods; D007117:Immunization, Secondary; D007156:Immunologic Memory / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008089:Listeria monocytogenes / Q000276:immunology; D008088:Listeriosis / Q000276:immunology / Q000382:microbiology; D008288:Malaria / Q000276:immunology / Q000469:parasitology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018448:Models, Immunological; D010047:Ovalbumin / Q000276:immunology; D010962:Plasmodium berghei / Q000276:immunology; D013997:Time Factors
chemical_list: D010047:Ovalbumin